Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings
Identifieur interne : 000E86 ( Main/Exploration ); précédent : 000E85; suivant : 000E87Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings
Auteurs : Shirley Owusu-Ofori [Royaume-Uni] ; Jillian Temple [Royaume-Uni] ; Francis Sarkodie [Royaume-Uni] ; Margaret Anokwa [Royaume-Uni] ; Daniel Candotti [Royaume-Uni] ; Jean-Pierre Allain [Royaume-Uni]Source :
- Transfusion [ 0041-1132 ] ; 2005-02.
Descripteurs français
- KwdFr :
- ADN viral (analyse), Donneurs de sang, Dépistage systématique (), Facteurs de risque, Ghana (épidémiologie), Humains, Hépatite B (), Hépatite B (transmission), Hépatite B (épidémiologie), Hépatite C (), Hépatite C (transmission), Hépatite C (épidémiologie), Infections à VIH (), Infections à VIH (transmission), Infections à VIH (épidémiologie), Maladies virales (), Maladies virales (transmission), Maladies virales (épidémiologie), Pathogènes transmissibles par le sang (isolement et purification), Pays en voie de développement, Prévalence, Techniques immunoenzymatiques.
- MESH :
- analyse : ADN viral.
- isolement et purification : Pathogènes transmissibles par le sang.
- épidémiologie : Ghana, Hépatite B, Hépatite C, Infections à VIH, Maladies virales.
- Wicri :
English descriptors
- KwdEn :
- Aids clinic, Allain, Assay, Blood Donors, Blood bags, Blood bank, Blood center, Blood donors, Blood pressure, Blood ranges, Blood safety, Blood transfusion, Blood unit, Blood units, Blood-Borne Pathogens (isolation & purification), Cambridge blood center, Candidate blood donors, Candidate donors, Clinical examination, Core antigen, DNA, Viral (analysis), Deferral, Developing Countries, Disposable tips, Donation, Donor, Donor care program, Donor screening, February, Ghana (epidemiology), HIV Infections (epidemiology), HIV Infections (prevention & control), HIV Infections (transmission), Hbsag, Hbsag reactivity, Hepatitis, Hepatitis B (epidemiology), Hepatitis B (prevention & control), Hepatitis B (transmission), Hepatitis C (epidemiology), Hepatitis C (prevention & control), Hepatitis C (transmission), Humans, Immunoenzyme Techniques, Individual donations, Individual samples, Komfo anokye teaching hospital blood bank, Kumasi, Mass Screening (methods), Mobile sessions, National blood service, Novel approach, Nucleic acid testing, Operational characteristics, Percent sensitivity, Plasma pools, Plasma samples, Positive pools, Positive samples, Postdonation triplex, Predonation, Predonation screening, Prevalence, Public health, Rapid test, Rapid testing, Rapid tests, Reactive, Replacement donors, Replacement unit, Residual risk, Risk Factors, Safe blood, Screening, Screening assays, Screening tests, Sera samples, Surface antigen, Test failures, Testing errors, Total number, Transfusion, Transfusion medicine, Transfusion volume, Triplex, Viral, Viral infections, Viral load, Viral markers, Viral screening, Virol methods, Virus Diseases (epidemiology), Virus Diseases (prevention & control), Virus Diseases (transmission), Virus infection, Volunteer candidate donors, Volunteer donors, West africa.
- MESH :
- chemical , analysis : DNA, Viral.
- geographic , epidemiology : Ghana.
- epidemiology : HIV Infections, Hepatitis B, Hepatitis C, Virus Diseases.
- isolation & purification : Blood-Borne Pathogens.
- methods : Mass Screening.
- prevention & control : HIV Infections, Hepatitis B, Hepatitis C, Virus Diseases.
- transmission : HIV Infections, Hepatitis B, Hepatitis C, Virus Diseases.
- Teeft :
- Aids clinic, Allain, Assay, Blood Donors, Blood bags, Blood bank, Blood center, Blood donors, Blood pressure, Blood ranges, Blood safety, Blood transfusion, Blood unit, Blood units, Cambridge blood center, Candidate blood donors, Candidate donors, Clinical examination, Core antigen, Deferral, Developing Countries, Disposable tips, Donation, Donor, Donor care program, Donor screening, February, Hbsag, Hbsag reactivity, Hepatitis, Humans, Immunoenzyme Techniques, Individual donations, Individual samples, Komfo anokye teaching hospital blood bank, Kumasi, Mobile sessions, National blood service, Novel approach, Nucleic acid testing, Operational characteristics, Percent sensitivity, Plasma pools, Plasma samples, Positive pools, Positive samples, Postdonation triplex, Predonation, Predonation screening, Prevalence, Public health, Rapid test, Rapid testing, Rapid tests, Reactive, Replacement donors, Replacement unit, Residual risk, Risk Factors, Safe blood, Screening, Screening assays, Screening tests, Sera samples, Surface antigen, Test failures, Testing errors, Total number, Transfusion, Transfusion medicine, Transfusion volume, Triplex, Viral, Viral infections, Viral load, Viral markers, Viral screening, Virol methods, Virus infection, Volunteer candidate donors, Volunteer donors, West africa.
Abstract
BACKGROUND: In sub‐Saharan Africa, the percentage of screened blood is limited to approximately 75 percent for human immunodeficiency virus antibodies (anti‐HIV), 50 percent for hepatitis B surface antigen, and 19 percent for hepatitis C virus antibodies (anti‐HCV), mainly because of costs.
Url:
DOI: 10.1111/j.1537-2995.2004.04279.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000127
- to stream Istex, to step Curation: 000127
- to stream Istex, to step Checkpoint: 000482
- to stream PubMed, to step Corpus: 000680
- to stream PubMed, to step Curation: 000680
- to stream PubMed, to step Checkpoint: 000680
- to stream Ncbi, to step Merge: 000162
- to stream Ncbi, to step Curation: 000162
- to stream Ncbi, to step Checkpoint: 000162
- to stream Main, to step Merge: 000F30
- to stream Main, to step Curation: 000E86
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings</title><author><name sortKey="Owusu Fori, Shirley" sort="Owusu Fori, Shirley" uniqKey="Owusu Fori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name></author><author><name sortKey="Temple, Jillian" sort="Temple, Jillian" uniqKey="Temple J" first="Jillian" last="Temple">Jillian Temple</name></author><author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name></author><author><name sortKey="Anokwa, Margaret" sort="Anokwa, Margaret" uniqKey="Anokwa M" first="Margaret" last="Anokwa">Margaret Anokwa</name></author><author><name sortKey="Candotti, Daniel" sort="Candotti, Daniel" uniqKey="Candotti D" first="Daniel" last="Candotti">Daniel Candotti</name></author><author><name sortKey="Allain, Jean Ierre" sort="Allain, Jean Ierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:57FDF1C85823C46BA34F16A9ECEDD737762B7C07</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1537-2995.2004.04279.x</idno><idno type="url">https://api.istex.fr/document/57FDF1C85823C46BA34F16A9ECEDD737762B7C07/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000127</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000127</idno><idno type="wicri:Area/Istex/Curation">000127</idno><idno type="wicri:Area/Istex/Checkpoint">000482</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000482</idno><idno type="wicri:doubleKey">0041-1132:2005:Owusu Fori S:predonation:screening:of</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15660820</idno><idno type="wicri:Area/PubMed/Corpus">000680</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000680</idno><idno type="wicri:Area/PubMed/Curation">000680</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000680</idno><idno type="wicri:Area/PubMed/Checkpoint">000680</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000680</idno><idno type="wicri:Area/Ncbi/Merge">000162</idno><idno type="wicri:Area/Ncbi/Curation">000162</idno><idno type="wicri:Area/Ncbi/Checkpoint">000162</idno><idno type="wicri:doubleKey">0041-1132:2005:Owusu Ofori S:predonation:screening:of</idno><idno type="wicri:Area/Main/Merge">000F30</idno><idno type="wicri:Area/Main/Curation">000E86</idno><idno type="wicri:Area/Main/Exploration">000E86</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings</title><author><name sortKey="Owusu Fori, Shirley" sort="Owusu Fori, Shirley" uniqKey="Owusu Fori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name><affiliation wicri:level="4"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>From the Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana; Department of Haematology, Division of Transfusion Medicine, University of Cambridge, Cambridge, UK; and the National Blood Service, Cambridge Blood Center, Cambridge</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Temple, Jillian" sort="Temple, Jillian" uniqKey="Temple J" first="Jillian" last="Temple">Jillian Temple</name><affiliation wicri:level="4"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>From the Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana; Department of Haematology, Division of Transfusion Medicine, University of Cambridge, Cambridge, UK; and the National Blood Service, Cambridge Blood Center, Cambridge</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name><affiliation wicri:level="4"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>From the Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana; Department of Haematology, Division of Transfusion Medicine, University of Cambridge, Cambridge, UK; and the National Blood Service, Cambridge Blood Center, Cambridge</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Anokwa, Margaret" sort="Anokwa, Margaret" uniqKey="Anokwa M" first="Margaret" last="Anokwa">Margaret Anokwa</name><affiliation wicri:level="4"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>From the Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana; Department of Haematology, Division of Transfusion Medicine, University of Cambridge, Cambridge, UK; and the National Blood Service, Cambridge Blood Center, Cambridge</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Candotti, Daniel" sort="Candotti, Daniel" uniqKey="Candotti D" first="Daniel" last="Candotti">Daniel Candotti</name><affiliation wicri:level="4"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>From the Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana; Department of Haematology, Division of Transfusion Medicine, University of Cambridge, Cambridge, UK; and the National Blood Service, Cambridge Blood Center, Cambridge</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Allain, Jean Ierre" sort="Allain, Jean Ierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name><affiliation wicri:level="4"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>From the Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana; Department of Haematology, Division of Transfusion Medicine, University of Cambridge, Cambridge, UK; and the National Blood Service, Cambridge Blood Center, Cambridge</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Royaume-Uni</country></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Transfusion</title><title level="j" type="alt">TRANSFUSION</title><idno type="ISSN">0041-1132</idno><idno type="eISSN">1537-2995</idno><imprint><biblScope unit="vol">45</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="133">133</biblScope><biblScope unit="page" to="140">140</biblScope><biblScope unit="page-count">8</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK and Malden, USA</pubPlace><date type="published" when="2005-02">2005-02</date></imprint><idno type="ISSN">0041-1132</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0041-1132</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aids clinic</term><term>Allain</term><term>Assay</term><term>Blood Donors</term><term>Blood bags</term><term>Blood bank</term><term>Blood center</term><term>Blood donors</term><term>Blood pressure</term><term>Blood ranges</term><term>Blood safety</term><term>Blood transfusion</term><term>Blood unit</term><term>Blood units</term><term>Blood-Borne Pathogens (isolation & purification)</term><term>Cambridge blood center</term><term>Candidate blood donors</term><term>Candidate donors</term><term>Clinical examination</term><term>Core antigen</term><term>DNA, Viral (analysis)</term><term>Deferral</term><term>Developing Countries</term><term>Disposable tips</term><term>Donation</term><term>Donor</term><term>Donor care program</term><term>Donor screening</term><term>February</term><term>Ghana (epidemiology)</term><term>HIV Infections (epidemiology)</term><term>HIV Infections (prevention & control)</term><term>HIV Infections (transmission)</term><term>Hbsag</term><term>Hbsag reactivity</term><term>Hepatitis</term><term>Hepatitis B (epidemiology)</term><term>Hepatitis B (prevention & control)</term><term>Hepatitis B (transmission)</term><term>Hepatitis C (epidemiology)</term><term>Hepatitis C (prevention & control)</term><term>Hepatitis C (transmission)</term><term>Humans</term><term>Immunoenzyme Techniques</term><term>Individual donations</term><term>Individual samples</term><term>Komfo anokye teaching hospital blood bank</term><term>Kumasi</term><term>Mass Screening (methods)</term><term>Mobile sessions</term><term>National blood service</term><term>Novel approach</term><term>Nucleic acid testing</term><term>Operational characteristics</term><term>Percent sensitivity</term><term>Plasma pools</term><term>Plasma samples</term><term>Positive pools</term><term>Positive samples</term><term>Postdonation triplex</term><term>Predonation</term><term>Predonation screening</term><term>Prevalence</term><term>Public health</term><term>Rapid test</term><term>Rapid testing</term><term>Rapid tests</term><term>Reactive</term><term>Replacement donors</term><term>Replacement unit</term><term>Residual risk</term><term>Risk Factors</term><term>Safe blood</term><term>Screening</term><term>Screening assays</term><term>Screening tests</term><term>Sera samples</term><term>Surface antigen</term><term>Test failures</term><term>Testing errors</term><term>Total number</term><term>Transfusion</term><term>Transfusion medicine</term><term>Transfusion volume</term><term>Triplex</term><term>Viral</term><term>Viral infections</term><term>Viral load</term><term>Viral markers</term><term>Viral screening</term><term>Virol methods</term><term>Virus Diseases (epidemiology)</term><term>Virus Diseases (prevention & control)</term><term>Virus Diseases (transmission)</term><term>Virus infection</term><term>Volunteer candidate donors</term><term>Volunteer donors</term><term>West africa</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ADN viral (analyse)</term><term>Donneurs de sang</term><term>Dépistage systématique ()</term><term>Facteurs de risque</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Hépatite B ()</term><term>Hépatite B (transmission)</term><term>Hépatite B (épidémiologie)</term><term>Hépatite C ()</term><term>Hépatite C (transmission)</term><term>Hépatite C (épidémiologie)</term><term>Infections à VIH ()</term><term>Infections à VIH (transmission)</term><term>Infections à VIH (épidémiologie)</term><term>Maladies virales ()</term><term>Maladies virales (transmission)</term><term>Maladies virales (épidémiologie)</term><term>Pathogènes transmissibles par le sang (isolement et purification)</term><term>Pays en voie de développement</term><term>Prévalence</term><term>Techniques immunoenzymatiques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>DNA, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>ADN viral</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Blood-Borne Pathogens</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Pathogènes transmissibles par le sang</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Hépatite B</term><term>Hépatite C</term><term>Infections à VIH</term><term>Maladies virales</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Aids clinic</term><term>Allain</term><term>Assay</term><term>Blood Donors</term><term>Blood bags</term><term>Blood bank</term><term>Blood center</term><term>Blood donors</term><term>Blood pressure</term><term>Blood ranges</term><term>Blood safety</term><term>Blood transfusion</term><term>Blood unit</term><term>Blood units</term><term>Cambridge blood center</term><term>Candidate blood donors</term><term>Candidate donors</term><term>Clinical examination</term><term>Core antigen</term><term>Deferral</term><term>Developing Countries</term><term>Disposable tips</term><term>Donation</term><term>Donor</term><term>Donor care program</term><term>Donor screening</term><term>February</term><term>Hbsag</term><term>Hbsag reactivity</term><term>Hepatitis</term><term>Humans</term><term>Immunoenzyme Techniques</term><term>Individual donations</term><term>Individual samples</term><term>Komfo anokye teaching hospital blood bank</term><term>Kumasi</term><term>Mobile sessions</term><term>National blood service</term><term>Novel approach</term><term>Nucleic acid testing</term><term>Operational characteristics</term><term>Percent sensitivity</term><term>Plasma pools</term><term>Plasma samples</term><term>Positive pools</term><term>Positive samples</term><term>Postdonation triplex</term><term>Predonation</term><term>Predonation screening</term><term>Prevalence</term><term>Public health</term><term>Rapid test</term><term>Rapid testing</term><term>Rapid tests</term><term>Reactive</term><term>Replacement donors</term><term>Replacement unit</term><term>Residual risk</term><term>Risk Factors</term><term>Safe blood</term><term>Screening</term><term>Screening assays</term><term>Screening tests</term><term>Sera samples</term><term>Surface antigen</term><term>Test failures</term><term>Testing errors</term><term>Total number</term><term>Transfusion</term><term>Transfusion medicine</term><term>Transfusion volume</term><term>Triplex</term><term>Viral</term><term>Viral infections</term><term>Viral load</term><term>Viral markers</term><term>Viral screening</term><term>Virol methods</term><term>Virus infection</term><term>Volunteer candidate donors</term><term>Volunteer donors</term><term>West africa</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Facteurs de risque</term><term>Humains</term><term>Hépatite B</term><term>Hépatite C</term><term>Infections à VIH</term><term>Maladies virales</term><term>Pays en voie de développement</term><term>Prévalence</term><term>Techniques immunoenzymatiques</term><term>Transfusion sanguine</term><term>Don</term><term>Santé publique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">BACKGROUND: In sub‐Saharan Africa, the percentage of screened blood is limited to approximately 75 percent for human immunodeficiency virus antibodies (anti‐HIV), 50 percent for hepatitis B surface antigen, and 19 percent for hepatitis C virus antibodies (anti‐HCV), mainly because of costs.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Angleterre de l'Est</li></region><settlement><li>Cambridge</li></settlement><orgName><li>Université de Cambridge</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Owusu Fori, Shirley" sort="Owusu Fori, Shirley" uniqKey="Owusu Fori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name></region><name sortKey="Allain, Jean Ierre" sort="Allain, Jean Ierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name><name sortKey="Allain, Jean Ierre" sort="Allain, Jean Ierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name><name sortKey="Anokwa, Margaret" sort="Anokwa, Margaret" uniqKey="Anokwa M" first="Margaret" last="Anokwa">Margaret Anokwa</name><name sortKey="Candotti, Daniel" sort="Candotti, Daniel" uniqKey="Candotti D" first="Daniel" last="Candotti">Daniel Candotti</name><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name><name sortKey="Temple, Jillian" sort="Temple, Jillian" uniqKey="Temple J" first="Jillian" last="Temple">Jillian Temple</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E86 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E86 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:57FDF1C85823C46BA34F16A9ECEDD737762B7C07
|texte= Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings
}}
| This area was generated with Dilib version V0.6.31. |  |